Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2010 Dec;40(3):544-54.
doi: 10.1016/j.nbd.2010.07.014. Epub 2010 Aug 2.

Cerebral cortex structure in prodromal Huntington disease

Collaborators, Affiliations
Multicenter Study

Cerebral cortex structure in prodromal Huntington disease

Peggy C Nopoulos et al. Neurobiol Dis. 2010 Dec.

Abstract

Neuroimaging studies of subjects who are gene-expanded for Huntington Disease, but not yet diagnosed (termed prodromal HD), report that the cortex is "spared," despite the decrement in striatal and cerebral white-matter volume. Measurement of whole-cortex volume can mask more subtle, but potentially clinically relevant regional changes in volume, thinning, or surface area. The current study addressed this limitation by evaluating cortical morphology of 523 prodromal HD subjects. Participants included 693 individuals enrolled in the PREDICT-HD protocol. Of these participants, 523 carried the HD gene mutation (prodromal HD group); the remaining 170 were non gene-expanded and served as the comparison group. Based on age and CAG repeat length, gene-expanded subjects were categorized as "Far from onset," "Midway to onset," "Near onset," and "already diagnosed." MRI scans were processed using FreeSurfer. Cortical volume, thickness, and surface area were not significantly different between the Far from onset group and controls. However, beginning in the Midway to onset group, the cortex showed significant volume decrement, affecting most the posterior and superior cerebral regions. This pattern progressed when evaluating the groups further into the disease process. Areas that remained mostly unaffected included ventral and medial regions of the frontal and temporal cortex. Morphologic changes were mostly in thinning as surface area did not substantially change in most regions. Early in the course of HD, the cortex shows changes that are manifest as cortical thinning and are most robust in the posterior and superior regions of the cerebrum.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Cortical Regions Volume. Starting from the left, each group of six maps represent the comparison of volume of separate cortical region between each prodromal HD group and the controls (Dx = diagnosed). Left hemisphere only is shown. The top row shows (from left to right) lateral and medial views, the second row shows dorsal and ventral views, the last row shows anterior and posterior views, respectively.
Fig. 2
Fig. 2
Cortical Thickness Maps. Starting from the left, each group of six maps represent the comparison of cortical thickness between each prodromal HD group and the controls (Dx = diagnosed). Left hemisphere only is shown. The top row shows (from left to right) lateral and medial views, the second row shows dorsal and ventral views, the last row shows anterior and posterior views, respectively.

References

    1. Abe O, Yamasue H, Aoki S, Suga M, Yamada H, Kasai K, et al. Aging in the CNS: comparison of gray/white matter volume and diffusion tensor data. Neurobiol Aging. 2008;29(1):102–16. - PubMed
    1. Aylward EH, Nopoulos P, Ross CA, Langbehn DR, Pierson R, Mills J, et al. Longitudinal change in regional brain volumes in preclinical Huntington disease. J Neurol Neurosurg Psychiatry. Forthcoming - PMC - PubMed
    1. Aylward EH, Anderson NB, Bylsma FW, Wagster MV, Barta PE, Sherr M, et al. Frontal lobe volume in patients with Huntington’s disease. Neurology. 1998;50(1):252–8. - PubMed
    1. Bartzokis G, Lu PH, Tishler TA, Fong SM, Oluwadara B, Finn JP, et al. Myelin breakdown and iron changes in Huntington’s disease: pathogenesis and treatment implications. Neurochem Res. 2007;32(10):1655–64. - PubMed
    1. Bartzokis G, Lu PH, Tishler TA, Perlman S. In vivo assessment of iron in Huntington’s disease and other age-related degenerative brain diseases. In: Sigel A, Sigel H, Sigel RKO, editors. Metal Ions in life sciences. Chichester: Wiley; 2006. pp. 151–77.

Publication types